- Home
- SM vs CRNX Comparison
SM vs CRNX Comparison
Compare SM & CRNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SM
- CRNX
- Stock Information
- Founded
- SM 1908
- CRNX 2008
- Country
- SM United States
- CRNX United States
- Employees
- SM N/A
- CRNX N/A
- Industry
- SM Oil & Gas Production
- CRNX Biotechnology: Pharmaceutical Preparations
- Sector
- SM Energy
- CRNX Health Care
- Exchange
- SM Nasdaq
- CRNX Nasdaq
- Market Cap
- SM 2.7B
- CRNX 2.8B
- IPO Year
- SM 1992
- CRNX 2018
- Fundamental
- Price
- SM $27.57
- CRNX $30.16
- Analyst Decision
- SM Buy
- CRNX Strong Buy
- Analyst Count
- SM 11
- CRNX 10
- Target Price
- SM $41.60
- CRNX $75.00
- AVG Volume (30 Days)
- SM 2.0M
- CRNX 676.7K
- Earning Date
- SM 08-06-2025
- CRNX 08-07-2025
- Dividend Yield
- SM 2.92%
- CRNX N/A
- EPS Growth
- SM 11.97
- CRNX N/A
- EPS
- SM 7.14
- CRNX N/A
- Revenue
- SM $2,847,233,000.00
- CRNX $760,000.00
- Revenue This Year
- SM $30.95
- CRNX $402.12
- Revenue Next Year
- SM $1.16
- CRNX $770.88
- P/E Ratio
- SM $3.86
- CRNX N/A
- Revenue Growth
- SM 24.88
- CRNX N/A
- 52 Week Low
- SM $19.67
- CRNX $24.10
- 52 Week High
- SM $50.20
- CRNX $62.53
- Technical
- Relative Strength Index (RSI)
- SM 63.70
- CRNX 41.11
- Support Level
- SM $26.85
- CRNX $32.05
- Resistance Level
- SM $28.70
- CRNX $31.56
- Average True Range (ATR)
- SM 1.19
- CRNX 1.08
- MACD
- SM 0.30
- CRNX -0.18
- Stochastic Oscillator
- SM 78.02
- CRNX 5.25
About SM SM Energy Company
SM Energy Co is an independent energy company engaged in the acquisition, exploration, development, and production of oil, gas, and NGLs in Texas and Utah. Its portfolio is comprised of assets in the Midland Basin of West Texas, the Maverick Basin of South Texas, and the Uinta Basin of northeastern Utah.
About CRNX Crinetics Pharmaceuticals Inc.
Crinetics Pharmaceuticals Inc is a clinical-stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for rare endocrine diseases and endocrine-related tumors. Its products include Paltusotine and Atumelnant.